Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma

  • Friederike Lämmer,
  • Claire Delbridge,
  • Silvia Würstle,
  • Frauke Neff,
  • Bernhard Meyer,
  • Jürgen Schlegel,
  • Kerstin A. Kessel,
  • Thomas E. Schmid,
  • Daniela Schilling,
  • Stephanie E. Combs

The raw data underlying Figs 3 and 4 are missing from the list of Supporting Information. The authors have provided the data as Supporting Information file S1 Dataset. With this correction [1], all relevant data are now provided.

The Data Availability statement for this paper is incorrect. The correct statement is: All relevant data are within the paper and its Supporting Information files.

Supporting information

S1 Dataset. Clinical data of individual patients.

https://doi.org/10.1371/journal.pone.0248612.s001

(XLSX)

Reference

  1. 1. Lämmer F, Delbridge C, Würstle S, Neff F, Meyer B, Schlegel J, et al. (2019) Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma. PLoS ONE 14(8): e0221502. https://doi.org/10.1371/journal.pone.0221502 pmid:31430337

Citation: Lämmer F, Delbridge C, Würstle S, Neff F, Meyer B, Schlegel J, et al. (2021) Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma. PLoS ONE 16(3): e0248612. https://doi.org/10.1371/journal.pone.0248612

Published: March 11, 2021

Copyright: © 2021 Lämmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.